Breaking News

JSR Life Sciences to Transfer Crown Bioscience to Adicon Holdings Ltd.

The strategic move will enable Crown Bioscience to operate as a standalone entity under Adicon's ownership.

Author Image

By: Charlie Sternberg

Associate Editor

JSR Life Sciences LLC, a provider of life sciences materials and services, has entered into a definitive agreement to transfer Crown Bioscience Inc. to Adicon Holdings Limited, an independent clinical laboratory provider in China and a portfolio company of The Carlyle Group. The transaction, subject to customary closing conditions, is expected to close in 2026. This strategic move will enable Crown Bioscience to operate as a standalone entity under Adicon’s ownership. Crown Bioscience&#...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters